Taltz (Ixekizumab) is a biologic medication approved for treating active ankylosing spondylitis. It works by targeting interleukin 17A, a protein that promotes inflammation. It's administered via subcutaneous injection every four weeks after initial loading doses. Common side effects include nausea, injection site Show Full Answer

Taltz (Ixekizumab) is a biologic medication approved for treating active ankylosing spondylitis. It works by targeting interleukin 17A, a protein that promotes inflammation. It's administered via subcutaneous injection every four weeks after initial loading doses. Common side effects include nausea, injection site reactions, and cold symptoms. Rare but serious risks include severe infections and inflammatory bowel disease exacerbations. For more details, visit: [Taltz](https://www.MySpondylitisTeam.com/treatments/taltz).

 This AI-generated response comes from MySpondylitisTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Taltz (Ixekizumab) for Spondylitis | MySpondylitisTeam

Humira (Adalimumab) for Spondylitis | MySpondylitisTeam